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Abstract – Marek’s disease virus type 1 (MDV-1) shows a strict dependency on the direct cell-to-cell
spread for its propagation in cell culture. As MDV-1 shows an impaired nuclear egress in cell culture,
we wished to address the characterization of capsid/tegument genes which may intervene in the
maturation of intranuclear capsids. Orthologs of UL17 are present in all herpesviruses and, in all
reported case, were shown to be essential for viral growth, playing a role in capsid maturation and
DNA packaging. As only HSV-1 and PrV UL17 proteins have been characterized so far, we wished
to examine the role of MDV-1 pUL17 in virus replication. To analyze MDV-1 UL17 gene function,
we created deletion mutants or point mutated the open reading frame (ORF) to interrupt its coding
phase. We established that a functional ORF UL17 is indispensable for MDV-1 growth. We chose to
characterize the virally encoded protein by tagging the 729 amino-acid long protein with a repeat of
the HA peptide that was fused to its C-terminus. Protein pUL17 was identiﬁed in infected cell
extracts as an 82 kDa protein which localized to the nucleus, colocalizing with VP5, the major capsid
protein, and VP13/14, a major tegument protein. By using green ﬂuorescent protein fusion and HA
tagged proteins expressed under the cytomegalovirus IE gene enhancer/promoter (PCMV IE), we
showed that MDV-1 pUL17 nuclear distribution in infected cells is not an intrinsic property.
Although our results strongly suggest that another viral protein retains (or relocate) pUL17 to the
nucleus, we report that none of the tegument protein tested so far were able to mediate pUL17
relocation to the nucleus.
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1. INTRODUCTION
Marek’s disease (MD) is a Tcell lymphopro-
liferative disease of chickens caused by an
oncogenic herpesvirus, Marek’s disease
virus (MDV) [4–6]. Marek’s disease virus
belongs to the Alphaherpesvirinae subfamily
and is the type species of the genus Mardivirus
[2, 9, 21, 38]. The horizontal spread of the virus
from infected to naı ¨ve birds relies on the
production of so-called cell-free virus in the
feather follicle epithelium [3], whereas the
spread of MDV in cell culture is restricted to
a direct transmission of the virus from an
infected cell to its uninfected neighbours,
referred to as direct cell-to-cell spread [10].
Tegument or glyco-proteins which are impli-
cated in the cell-to-cell spread are essential for
MDV [14, 28, 33] or varicella zoster virus
(VZV) [36], and dispensable for most other
herpesviruses whereas MDV [14]o rV Z V[ 7]
do not need a functional VP16, which plays a
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egress [22, 42]. To improve our knowledge on
the roles of MDV tegument proteins in virus
replication, we chose to focus our studies on
the proteins which contribute to the inner layer
of the tegument and interact with the capsid. In
this group of proteins, pUL17 protein orthologs
are found in alpha-, beta- and gamma-
herpesviruses [17, 26, 40]. In HSV-1 the
UL17 gene encodes a 78 kDa protein which
is essential for virus replication and required
for cleavage and packaging of the viral DNA
[15, 26]. HSV-1 pUL17 has been assigned a
role in targeting the capsids to intranuclear
replication compartments where the viral
DNA is packaged and cleaved [30] and has
been shown to recruit pUL25 [32]. In Pseudo-
rabies Virus (PrV) the cleavage/packaging
activity is conserved but, unlike that of HSV-1
[31], pUL17 was not detected as a tegument
associated protein [18].
To characterize MDV pUL17 we con-
structed deletion and HA-epitope- or mono-
meric-Red-Fluorescent-Protein (mRFP)-tagged
mutants by using Bacterial Artiﬁcial Chromo-
some (BAC) clones both of the highly
pathogenic RB-1B MDV-1 strain [24]a n do f
the cell-adapted Bac20 MDV-1 virus [27]. We
could show that MDV-1 pUL17 is essential
forviralreplication,and thatthis 82 kDa protein
localizestothenucleusofinfectedcells,colocal-
izing partially with the major capsid protein
(VP5) and a tegument protein, VP13/14. The
localisation of pUL17 as ﬂuorescent dots seen
in virus infected cells is not an intrinsic property
of the protein nor a result of its interaction with
tegument proteins.
2. MATERIALS AND METHODS
2.1. Cells and viruses
C h i c k e ne m b r y os k i nc e l l s( C E S C )c u l t u r ea n d
propagation of viruses on CESC have been described
[13, 14]. DF-1 cells [16] were cultivated in the same
conditions as CESC. COS-7 cells were maintained in
William’s E medium (Invitrogen, Cergy Pontoise,
France) with 5% FCS (Invitrogen).
2.2. Bacteria, plasmids and BAC
Top 10 Escherichia coli (Invitrogen) were used
for plasmids pEGFP-C1 (Clonetech, St. Germain-
en-Laye, France), pFuse (InvivoGen, Toulouse,
France), pEPKan-S and pBAD-I-SceI[ 35], or their
derivatives and the derivatives of pGEM-T plasmids
(Promega, Charbonnie `res-les-Bains, France). The p
dependent plasmid pSU311 and its derivative
pSU311-2X-HA-Kan
R were maintained in E. coli
strain MA6931 and MA 6717 pyr+, respectively
[39]. BAC ampliﬁcation and Red recombination
were performed in E. coli EL250 [20] containing
either pRB-1B (MDV-1 strain RB-1B BAC) [24]o r
Bac20 (MDV-1 strain 584Ap80c BAC) [27].
Antibiotics were used at the following concentra-
tions: chloramphenicol, 34 lg/mL; kanamycine or
ampicillin, 50 lg/mL and zeocin 25 lg/mL.
2.3. Primers
Primers are listed in Table I and those speciﬁc for
MDV-1 genes were selected on the basis of MDV-1
Md5 sequence [38].
2.4. Deletion of UL17 and generation
of rescued viruses
Aﬁ r s tm u t a n t( p R B - 1 B D17) was generated in
pRB-1B, in which the entire UL17 gene was replaced
by a Kan
R cassette obtained by PCR ampliﬁcation
with pKD4 [8] as a template plasmid and primers
UL17delFw and UL17delRev (Tab. I). Selection for
recombinant BAC and subsequent analyses were per-
formed as described [29]. A second mutant, pRB-
1B17stop, was constructed by mutating the second
start codon from ATG to TAG. Mutant pRB-
1B17stop was obtained by using the two-step red
mutagenesis method [35] with primers UL17delFw2
and UL17delRev2. Rescuant viruses were obtained
by co-transfection of mutagenized BAC with a com-
plementing plasmid harbouring UL17 gene and
500 bp sequences immediately up and downstream
of the gene. The region encompassing UL17 and
additional sequences was PCR ampliﬁed from
pRB-1B using primers UL17ResA and UL17ResB
(Tab. I), and cloned in pGEM-T Easy, yielding
pGEM-T17R. Rescued viruses were obtained as
described [14], by co-transfection of either pRB-
1BD17 or pRB-1B17stop DNA with pGEM-T17R,
and named rRB-1BD17R or rRB-1B17StopR.
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Primer Sequence 50-30
Bac17-F GGATCCATGGAGGCGCATATAGAAAGCGAA Underlined, BamHI site
Bac17-R GCGGCCGCTCACATATACACCTCTGAAACGTA Underlined, NotI site
pF-Forw GATATCCGCCACCATGTTTGCAGTGAGCGC Underlined, EcoRV site
pF-Rev AGATCTTACACAGCTGTCTGAGACATCG Underlined, BglII site
2·-HA-Fw GAATTCTATCCGTATGATGTTCCTGATTATGCTA
GCCTCTATCCGTATGATGTTCCTGATTATGCTAGCCTC
GTGTAGGCTGGAGCTGCTTC
Bold, EcoRI site;
underlined, 2·HA
tag sequence
2·-HA-Rev GAATTCCATATGAATATCCTCCTTAG Bold, EcoRI
UL17-Fw AAGATGCAACAGGTGCTACGACCTTACGTTTCAGAGG
TGTATATGTATCCGTATGATGTTCCTGATTAT
Underlined, sequences
annealing to template
plasmid pSU311-2·HA
UL17-Rev TCTTCAGTCTCTGCGTAGTCATAATTCAATACCTGTGTT
GAGGATTGGCATATGAATATCCTCCTTAG
UL49-Fw CGTCGCCATCATTCATCCGCCCGCGGATATCGTAGCAG
TGATAGCGAATATCCGTATGATGTTCCTGATTAT
UL49-Rev TAGATAAGATATATATGTACTAGTTTTTAATTCGGATGT
CTATAAAAGCATATGAATATCCTCCTTAG
UL48-Fw AATTCAATTTCCCCTGGTGATCCTGTTGCCACTACCAT
CAGTACTTTATATCCGTATGATGTTCCTGATTAT
UL48-Rev CGAATACGACAAATTCGTTTATTAAACGTCACATTTA
CGTATAATATCCATATGAATATCCTCCTTAG
PX1 GCGGCAGCGTGAGGGGATCTTGAAG Speciﬁc of Kan
R gene
PX2 CCCCAGCTTCAAAAGCGCTCTGA Speciﬁc of Kan
R gene
T497 GCATCTAGCACTTGGAGA Speciﬁc of UL49 gene
T500 CCCTGCCCATGCCTCCCA Speciﬁc of UL48 gene
DelTag17 CAGGTGGCTGTGTACGTTC Speciﬁc of UL17 gene
UL17delFw GGTATCTTCAGTCTCTGCGTAGTCATAATTCAATAC
CTGTGTTGAGGACATATGAATATCCTCCTTAG
Deletion of UL17
UL17delRev GACCTTAGTCACAACATTGGTGCACGTAGGCAAC
ACGACGGATAACAGCGGTGTAGGCTGGAGCTGCTTCG
UL17delRev2 GAAACTATATATTCATTATCTAACTTTGATCGGG
GGGCGTAGCGACATCTGTTAACACATAGGATGACGA
CGATAAGTAGGG
Mutation of the 2d
start codon of UL17.
Bold, complementary
sequences; grey box,
mutation; underlined,
sequences annealing to
template plasmid
pEPkan-S
UL17delFw2 CATTCATCAGGTATTATTATATGTGTTAACAGATGT
CGCTACGCCCCCCGATCAAAGTTACAACCAATTA
ACCAATTCTGATTAG
UL17ResA CTATGCACGGTGTCGTCGGT
UL17ResB TCCTGCATAAACGAATCCGG
UL17seqA CCCGTAGCATTCTGTCGTATTTGAACG
UL17RFP1 gtatcttcagtctctgcgtagtcataattcaatacctgtgttgaggattgg
TCACAAGGCGCCGGTGGAGTGG
Uppercase, sequences
annealing to template
plasmid pEPmRFPin UL17RFP2 accaacaagatgcaacaggtgctacgaccttacgtttcagaggtgtatatg
ATGGCCTCCTCCGAGGACGTCATC
B17F cccgGGATCCatggaggcgcatatagaaag Underlined, BamHI site
Xh17r agatCTCGAGctacacgaggctagcataatc Underlined, XhoI site
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2.5.1. HA epitope tagging at the 30 end of genes
Epitope tagging of targeted MDV genes was
based on the method described by Uzzau et al.
[39]. A template plasmid containing a repeat of a
HA epitope and the kanamycin resistance gene
(Kan
R) ﬂanked by FRT sites and was constructed
by cloning the PCR fragment obtained with pKD4
plasmid as a template [8] and primers 2·-HA-Fw
and 2·-HA-Rev (Tab. I). The forward primer con-
tained a 33 nt extension corresponding to the
sequence of the HA tag [23]. The PCR fragment
was cloned in pGEM-T Easy, sequenced, released
by EcoRI digestion and ligated into EcoRI digested
pSU311 plasmid to obtain template plasmid
pSU311-2·-HAKan
R. To insert the HA epitope
at the end of a gene, a PCR ampliﬁcation was
performed with pSU311-2·-HAKan
R as a template
and primers carrying extensions homologous to the
end of the gene (forward primer) and to the genome
region immediately downstream of it (reverse
primer). Primers UL17-Fw and -Rev were used to
tag UL17, UL49-Fw and -Rev for UL49 and
UL48-Fw and -Rev for UL48 (Tab. I). PCR
fragments were inserted in pRB-1B as described
[14, 20, 29]. Insertion of the tag cassette was
checked by PCR, Southern blotting and sequencing.
PCR and sequencing were performed by using prim-
ers PX1, PX2, T497, T500 and Deltag17 (Tab. I).
2.5.2. Insertion of the mRFP
at the end of UL17
Fusion of the mRFP to the C-terminus of pUL17
was performed in pRB-1B and Bac20 using primers
UL17RFP1 and UL17RFP2 (Tab. I), as described
[35].
2.6. DNA analyses
BAC modiﬁcations were characterized by RFLP
and Southern blot analysis, by using a Kan
R speciﬁc
probe and a chemoluminescence detection kit
(ECL
TM, Amersham-Biosciences, Little Chalfont,
UK) [14]. Primers PX1 and PX2 (Tab. I)w e r eu s e d
to sequence verify the correct insertion of the cassette
and in pRB-1B17Stop the mutation was conﬁrmed
by sequencing with primer UL17seqA (Tab. I).
2.7. MDV-1 reconstitution and propagation
Transfection of CESC by BAC DNA, subsequent
viral passages and growth kinetic studies of pRB-1B
and pRB-1Btag17 derived viruses were performed as
described [14, 27].
2.8. Indirect immunoﬂuorescence
CESC were seeded on round coverslips (14 mm
in diameter), in 24-well plates, at 1 · 10
5 cells per
well. One-day old CESC were either transfected with
BAC DNA or infected with viruses. Cells were then
incubated at 41  C for 2 to 4 days, ﬁxed, permeabi-
lised and probed with antibodies. Anti-HA antibodies
used were either a mouse Mab HA-7 (Sigma-Aldrich,
St. Quentin-Fallavier, France) at 1:10 000 or a poly-
clonal rabbit anti-HA (Sigma H6908) at 1:4 000.
Monoclonal antibodies to tegument or capsid proteins
have been described [13, 14, 34]. Anti-mouse IgG
Alexa-Fluor conjugates (Invitrogen) were used to
label bound antibodies. Double immunostaining
was carried out by using anti-VP22 or anti-VP5
Mabs conjugated to Oregon Green (FluoReporter
labelling kit, Invitrogen). Cell nuclei were stained
with Hoechst 33342 dye and coverslips were
mounted on a drop of Vectashield medium (Vector
lab. ABCYS, Paris, France). A minimum of 50
infected cells were examined for the nuclear or cyto-
plasmic localization of viral proteins with a Zeiss
Axiovert 200 microscope equipped with the
Apotome imaging system. Images were generated
and analyzed by using the Axiovision Software (Carl
Zeiss SA, Le Pecq, France).
2.9. Immunoblot analyses
Cell extracts were prepared from infected or
mock-infected CESC at 4 days post infection. Cells
were trypsinized, washed in PBS and centrifuged at
200 · gf o r1 0m i na t4 C. Cell pellets were then
incubated in RIPA buffer (50 mM Tris-HCL pH 8,
150 mM NaCl, 1 mM MgCl2, 1% NP40), containing
protease inhibitors (Complete Mini EDTA free,
Roche, Meylan, France), 0.5 mM PMSF (Sigma-
Aldrich), 1 mM DTT and benzonase (25 U/lL) for
90 min at 4  C. After centrifugation at 7 800 · g
for 30 min at 4  C, cell pellets were resuspended in
sample buffer [19] and heated in boiling water for
2 min. Proteins were separated on SDS-polyacryl-
amide gels, electroblotted to nitrocellulose mem-
branes (Qbiogene, Strasbourg, France) [13]. Protein
Vet. Res. (2009) 40:28 N. Chbab et al.
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6 cells were loaded
in each lane. Immunodetection was done as described
[13] ,a n dt a g g e dp r o t e i n sw e r ed e t e c t e db yu s i n gt h e
anti-HA7 Mab diluted 1:5 000 and an anti-mouse
IgG conjugated to alkaline phosphatase (Sigma-
Aldrich). Bound antibodies were detected by using
the NBT-BCIP substrate (Zymed, Invitrogen).
2.10. Cloning of MDV-1 genes
in expression vectors
MDV-1 UL17 gene was PCR ampliﬁed from
pRB-1B with primers Bac17F and Bac17R. The frag-
ment was cloned in pGEM-T Easy, sequenced,
released by BamHI–NotI digestion and cloned in
the same sites of pFastBac1 vector (Invitrogen).
The UL17 gene was then released from pFastBac1-
UL17 by BamHI–HindIII and cloned into the BglII
HindIII sites of pEGFP-C1, yielding pEGFP-UL17.
The MDV-UL17 tagged gene was PCR ampliﬁed
from pRB-1Btag17 by using primers B17F and
Xh17R (Tab. I) and cloned in BamHI-XhoIs i t e so f
pCDNA3 vector yielding pCDNA3-UL17HA. The
MDV-1 UL14 gene was PCR-ampliﬁed with primers
pF-Forw and pF-Rev and the 700 bp fragment was
cloned in pGEM-T, sequenced and transferred to
pFuseFc plasmid (InvivoGen – CAYLA InvivoGen)
by using EcoRVa n dBglII sites. The recombinant
pFuse-UL14 plasmid encoded the UL14 gene fused
to the Fc portion of a mouse IgG2a.
3. RESULTS
3.1. pUL17 is essential for replication of MDV
in cultured cells
Insertion of the Kan
R cassette at the UL17
locus (Fig. 1A) in pRB-1BD17 was conﬁrmed
by RFLP and Southern blot analyses
(Fig. 1B). Sequencing conﬁrmed the correct
insertion of the cassette (data not shown).
pRB-1BD17 DNA was transfected into CESC
to analyze the effect of UL17 open reading
frame (ORF) deletion on viral growth. At 3
days post-transfection the presence of isolated
cells expressing the major tegument and capsid
protein VP22 and VP5 could be detected; but
no cell to cell transmission of the virus was
observed. After four serial blind passages on
CESC no viral replication could be detected
in three independent transfections. Parallel
transfection of the parental pRB-1B DNA con-
sistently yielded viable virus. As co-transfection
of pRB-1BD17 with rescue plasmid pGEM-
T17R yielded a viable rescued virus,
rRB-1BD17R, we concluded that the UL17
knock-outed virus was not able to undergo a
complete replication cycle that would result in
the production of a progeny. However the local-
ization of UL17 in the intron of another puta-
tively essential gene, UL15, prompted us to
verify that the phenotype observed was directly
related to the absence of UL17 and not to a neg-
ative effect of the deletion on the expression of
neighbouring genes. Site speciﬁc mutagenesis
of the second start codon to a stop codon
(ATG > TAG) was performed. After veriﬁcation
of the sequence (Fig. 1C), the resulting BAC
DNA (pRB-1B17Stop) was transfected in
CESC. As described for the UL17 deletion
mutant, no viral progeny could be obtained
from 3 independent transfection. Major capsid
and tegument proteins could be detected in sin-
gle cells in the same conditions as above
(Fig. 1D). A rescued virus (rRB-1B17Stop)
was obtained by co-transfection of pRB-
1B17Stop DNA and pGEM-T17R. As both
rRB-1B17Stop and rRB-1BD17 showed no
obvious differences in replication when com-
pared with vRB-1B virus originating from the
parental BAC pRB-1B (data not shown), we
concluded that MDV-1 UL17 gene was essen-
tial for viral growth in vitro.
3.2. Epitope tagging of MDV-1 UL17 gene
AsnoantibodyagainstpUL17wasavailable,
we constructed a recombinant MDV-1 express-
ingapUL17witharepetitionoftheHAepitope,
fusedtoitsCterminalend.Theinsertionofatag
sequence at the 30 end of a gene was performed
using Red recombination in EL250 [20]c o n -
taining pRB-1B, with a PCR fragment obtained
by using the primers described and pSU311-
2·-HA-Kan
R as a template (Fig. 2A). We
obtainedpRB-1Btag17,amutatedBACcarrying
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were constructed as controls, pRB-1Btag49 and
pRB-1Btag48inwhichgenesUL49and48were
similarly modiﬁed to encode tagged VP22 and
VP16 respectively. After an initial screening
based on PCR, the genotypes of the resulting
BAC were conﬁrmed by RFLP and Southern
blotting (Fig.2B). Digestion with PstI generated
2 additional fragments (2.7 and 1.3 kB) in pRB-
1B17tag DNA (Fig. 2B). Similarly, two new
fragments of approximately 13 and 12 kbp were
generated by NheI digestion of pRB-1Btag49
UL15 exon I  UL15 exon II UL17  UL16
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Figure 1. Inactivation of UL17 gene is lethal for MDV replication. (A) Schematic representation of the
genomic localization of the MDV UL17 gene. The unique long (UL), unique short (US), and repeated (IR,
TR) sequences are indicated. (B) Southern blot analysis of HindIII digests of pRB-1B (lane 1) and pRB-
1BD17 (lane 2). Hybridization with a Kan
R speciﬁc-probe reveals the insertion of the cassette in the UL17
locus. (C) Sequence analysis of UL17 gene conﬁrming the alteration of codon 21 from ATG (CAT in the
complementary strand) in pRB-1B (WT) to TAG in the pRB-1B17stop mutant (MUT). (D) vRB-1B17Stop
mutant viruses does not spread to neighbouring cells: CESC transfected with pRB-1B17stop DNA were
ﬁxed at 120 h p.i. Co-staining of VP22 (green) and VP5 (red) shows replication of mutant virus limited to
the transfected cell.
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Figure 2. Tagging of viral genes. (A) Schematic representation of the tagging strategy: (a) A DNA fragment
beginningwiththeHA-encoding sequence (hatched box) andincludinga kanamycin-resistance cassette(Kan
R)
ﬂankedbytheFRTsites(ﬁlledbox)wasampliﬁedwithprimerscarryinganextensionof45-48nthomologousto
the region immediately upstream of the translation stop signal of the target gene (dotted box) and to a region
downstream from it (shaded box). (b) The modiﬁed sequence was incorporated by homologous recombination
inpRB-1B.(B)RestrictionenzymedigestionandSouthernblotanalysisoftaggedpRB-1Bclones.pRB-1B(A)
and pRB-1Btag17 (B) DNAwere digested with PstI, while pRB-1Btag49 (D) and pRB-1Btag48 (E) and, as a
control, pRB-1B (C) DNA were digested with NheI. Asteriks indicate new fragments in tagged BAC DNA.
Southern blot analysis revealed the presence of the cassette in the newly generated fragments (lane B0,
pRB-1Btag17; lanes D0 &E 0, pRB-1B tag49 and 48 respectively).
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conﬁrmed the presence of the Kan
R gene in the
tagged mutants (Fig. 2B). Sequencing of the
recombination site with primers PX1 and PX2
conﬁrmed the insertion of the fragment in the
desired genome loci (data not shown).
3.3. Reconstitution of MDV-1 expressing pUL17
tagged protein
The DNA from pRB-1Btag17 or pRB-1B
were transfected into CESC to obtain tagged
(vRB-1Btag17) or parental (vRB-1B) viruses.
Typical MDV-1 plaques were observed after
transfection of both parental and tagged mutant.
The growth kinetics of the mutant and parental
virus were similar as no signiﬁcant differences
could be observed (Simstat statistical analyses
on two independent experiments) (Fig. 3).
3.4. Characterization of pUL17
in MDV-infected cells
The expression of pUL17 was monitored by
western blotting analyses in infected CESC
lysates. In NP40 insoluble extracts of CESC
infected with vRB-1Btag17, Mab HA-7 reacted
with a protein of approximately 82 kDa (Fig. 4,
lane 3), which is in good agreement with the
predicted molecular mass of pUL17 (81 kDa).
Control experiments showed no back ground
staining in lysates from CESC or vRB-1B
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Figure 3. Growth curves of vRB-1B and vRB-1Btag17 viruses. CESC were infected with 100 PFU of
virus, and titres were determined at the indicated time p.i.
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MabHA-7 clearly delineated a doublet of bands
(33 & 30 kDa) corresponding to VP22 in
vRB-1Btag49 lysates and a unique protein
migrating at 55 kDa (VP16) in vRB-1Btag48
infected CESC (Fig. 4, lanes 1 & 2). The tagged
VP22 was also detected by a monoclonal anti-
bodyL13a(data notshown). Ourdata show that
HA tagging of pUL17 allowed its speciﬁc iden-
tiﬁcation in CESC infected with vRB-1BTag17
and allowed further analyses of its expression.
3.5. MDV-1 pUL17 is a nuclear protein
Intracellular localization of pUL17 was ana-
lyzed in vRB-1Btag17 infected cells, and its
colocalization with other viral proteins was
established by double immunostaining. When
stained with anti-HA antibodies, the tagged
pUL17associatedsignalappearedasapunctuate
intranuclear signal, partly associated with the
nuclear membrane (Fig. 5, panel A). The
pUL17 staining was observed only in
vRB-1Btag17 infected CESC, in association
with two other intranuclear viral proteins, the
MCP VP5 (Fig. 5, panel A) and the major tegu-
ment protein VP13/14 (see below). The intranu-
clear localisation of pUL17 associated
ﬂuorescence was not an artefact related to its
tagging with HA peptide as a similar location
was observed when pUL17 was fused in frame
with the mRFP, in vRB-1BmRFPUL17 and
vBAC20mRFPUL17 (Fig. 5, panel C). A very
limited colocalization of pUL17 with MCP
VP5 or VP13/14 could also be observed in the
nuclei,closeto or inassociationwiththenuclear
membrane(Fig.6,panelA&B).Byusingatag-
ging strategy, we show that pUL17 localizes in
the nuclei of infected CESC, in association with
the major capsid protein VP5 and with the tegu-
ment protein VP13/14.
3.6. The discrete nuclear localization of pUL17
is not an intrinsic property
AsnocanonicalNLScouldbepredictedfrom
the amino-acid sequence of pUL17, we checked
whethertheproteinwoulddisplayasimilarloca-
tion when expressed under the PCMV IE pro-
moter. A ﬁrst green ﬂuorescent protein (GFP)
fusion was constructed in pEGFPC1 in which
the GFP was fused to the N term of pUL17. In
CESC the fusion protein localized predomi-
nantly in the cytoplasm, forming brightly ﬂuo-
rescent aggregates although a lower amount of
the protein could be detected in the nucleus
1
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41.6
28.2
81.8-
68.4-
55-
41.6-
28.2-
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2 3 4 5
Figure 4. pUL17 expression in CESC. Proteins in NP40 insoluble fraction of CESC infected with
vRB-1Btag49 (1) vRB-1BTag48 (2) vRB-1Btag17 (3) vRB-1B (4) or mock-infected (5) were separated by
PAGE, blotted and probed with MAb HA-7. Arrowheads point to the respective positions of tagged
proteins. Molecular mass markers are on the left and right (Chemicon).
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(page number not for citation purpose) Page 9 of 16Figure 5. Expression and subcellular location of MDV-1 pUL17. CESC were infected with vRB-1Btag17
(A) or vRB-1B (B) and stained for pUL17 (anti-HA tag-Red) and either VP5 (A) or VP22 (B) (green). The
localisation of pUL17 is unaffected by the size of the tag sequence (C): CESC were infected with vRB-1
B-UL17mRFP (left) or vBac20UL17mRFP (right). The mRFP tagged protein displays the red signal in
nuclei where the presence of VP5 is also detected (green).
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tributedinthenucleusandcytoplasmofthecells
(Fig. 7B). These aggregates appeared early after
transfection, in primary CESC as well as in DF1
cells(Fig.7C).Toascertainthatthetaggingstrat-
egy or the expression under a strong promoter
were not inducing an artifactual expression of
pUL17, we cloned the tagged UL17-HA from
pRB-1Btag17 in pCDNA3 and compared the
subcellular localizations of the HA tagged pro-
tein with the GFP-UL17, in chicken DF1 and
in mammalian COS-7 cells. The localization of
UL17-HA expressed from pCDNA3-UL17-
HA, was predominantly cytoplasmic, although
again a faint intranuclear signal could be
observed (Fig. 7D). The C-terminal HA tagged
proteinwasconsiderablylessprompttoaggrega-
tion than the GFP fusion protein, in the chicken
cells(Fig.7C&D).Inmammaliancells(COS-7)
theUL17-HAproteinshowedalocalizationsim-
ilar to what was already observed in DF1
(Fig. 7E – left panel), but GFP-UL17 did not
form large cytoplasmic aggregates and showed
a pattern of localization much similar to the
one of UL17-HA (Fig. 7E – right panel). From
theseexperimentweconcludedthatthelocaliza-
tion of pUL17 in transfected cells was predomi-
nantly cytoplasmic and that this distribution was
representative of the expression of pUL17 as a
transgene in avian and mammalian cells. As this
subcellular localization differed considerably
from what was reported in infected cells, we
wondered whether any tegument protein could
retain or relocate pUL17 to the nucleus. How-
ever none of the tegument protein tested
(pUL11/12;pUL13/14;VP22,andpUL14)were
Figure 6. pUL17 colocalizes partially with the major capsid protein VP5 (A) and the tegument protein
VP13/14 (B) in the nucleus of vRB-1B-tag17 infected CESC. Anti-HA rabbit antibody (red) reveals the
pUL17 tagged protein and VP5 or VP13/14 (green) were identiﬁed using speciﬁc monoclonal antibodies
H18 and L13b. The colocalized signals were extracted from a single slice and presented in the left panel of
A and B.
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(page number not for citation purpose) Page 11 of 16Figure 7. ThediscretepUL17nuclear localisationisnotanintrinsicproperty.Whenexpressedinfusionwith
eGFP, pUL17 localizes mainly in the cytoplasm in transfected CESC (A) whereas eGFP alone is randomly
distributed in the cell (B). A similar localization is observed for the GFP-UL17 in DF1 cells (C). The
localizationofUL17-HA,expressedfrompCDNA3-UL17-HA,wasalsopredominantlycytoplasmichowever
the recombinant protein did not form large aggregates in the cytoplasm (D). When expressed in COS-7 cells,
theHAtagged(Eleftpanel)ortheGFPfusionprotein(Erightpanel)showedsimilarﬂuorescencepatterns.The
HA tag was revealed by staining with anti-HA7 monoclonal antibody and an anti-mouse antibody conjugated
to Alexa 488. The nuclei were counterstained with Hoechst 33342 dye.
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(Data not shown).
4. DISCUSSION
We aimed at characterizing pUL17 of
MDV-1 by generating deletion and tagged
mutants in pRB-1B. By deleting (pRB-
1BD17) or mutating (pRB-1B17Stop) the
UL17 gene we showed that this ORF was
essential for MDV-1 growth in cell culture,
and that this growth defect could be cured by
restoring the UL17 locus as previously shown
for UL17 gene orthologs in HSV-1 and PrV
[18, 26]. To further characterize the protein
coded by UL17 in MDV-1, we developed a
tagging strategy enabling the fusion of the
HA epitope [23], at the C-terminus of the pro-
tein. We designed the method to (i) generate
recombinant viruses in a one-step Red recombi-
nation procedure; (ii) avoid the isolation of
false-positive double resistant colonies by using
a p dependent plasmid [39]. We also show that
we could generate tagged mutants without
introducing deletions in downstream intergenic
sequences. We constructed a recombinant
pRB-1B molecule encoding a C-terminally
tagged UL17 protein and used it to characterize
the expression of pUL17 in MDV-1. In
pRB-1Btag17, as well as in other tagged recom-
binants, we found that the insertion had no
obvious impact on virus viability, protein
expression level and location
1. We demonstrate
that the use of commercially available anti-HA
antibodies enabled us to detect the tagged
pUL17, as well as another weakly expressed
MDV-1 tegument protein, VP16, in infected
cell-lysates. This improved detection of viral
proteins is in good agreement with the recent
report by Adler et al. [1] who described a higher
sensitivity of anti-HA antibody compared to a
monospeciﬁc antiserum for the detection of
HCMV pUL131A. MDV-1 pUL17, a 82 kDa
protein, was associated with the NP40 (and
Triton X100) insoluble fraction and this pre-
cluded any attempt to probe it for interaction
with other proteins by co-immunoprecipitation.
The cellular location of pUL17 in rRB-1Btag17
infected cells was nuclear, as reported for other
alphaherpesviruses. Protein pUL17 colocalized
partially with VP5, probably delineating the
replication compartment(s) [15, 18]. A discrete
and very limited co-localization was also
observed with VP13/14, an observation that
had not been reported earlier. Whether this co-
localization corresponds to the delineation of
the same replication compartment remains to
be established, but VP13/14 was also reported
to localize to replication compartments in
HSV-1 infected cells [11, 12]. In PrV it was
hypothesized that the nuclear localization of
pUL17 was mediated by a NLS [18], but no
such signal could be predicted from the
amino-acid sequence of MDV-1 pUL17. The
absence of a strong NLS was conﬁrmed
as pUL17 was observed mainly in the cyto-
plasm of the cells transfected with plasmids
expressing either HA tagged or GFP fusion pro-
tein. The presence of minute amounts of
nuclear pUL17 was recorded in almost all
instances, although no amino acid sequence
could be predicted as mediating this relocation.
Whether the viral pUL17 is retained to the
nucleus or relocated through its interaction with
one or several proteins remains to be estab-
lished, but our results strongly suggest that,
for MDV-1, this (these) protein(s) are either
of viral origin or induced by viral infection.
Further identiﬁcation of MDV pUL17 ligands
was rendered difﬁcult due to the insolubility
of the protein, limited virus titres and high
cell-association of MDV-1. No information on
pUL17 ligands could be obtained from litera-
ture [41]. In HSV-2, pUL14 was reported to
inﬂuence the intracellular location of a number
of proteins including VP26, pUL33 and pUL17
[43]. However none of the tegument proteins
tested so far, including MDV-1 pUL14, were
able to retain or relocate pUL17 to the nucleus.
The interaction of pUL17 with capsid proteins
has not been extensively studied but recent pub-
lications on the capsid structure showed that the
pUL17-pUL25 complex is located at the penton
1 Chbab N., Re ´plication et morphoge ´ne `se du virus
MDV-1 : caracte ´risation d’une prote ´ine de te ´gu-
ment produit du ge `ne UL17 essentiel a `l ar e ´plica-
tion virale, The `se d’Universite ´, Universite ´ Franc ¸ois
Rabelais, Tours, France, 2006.
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it could be through a direct or indirect interac-
tion with the triplex protein VP19c as it is
known to relocate both VP5 and VP23 to the
nucleus [25], and has recently shown to be in
a good conformation to interact with the
pUL17-pUL25 complex [37].
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